The Practical Technical Aspects of Slow Continuous Ultrafil Tration (SCUF) and Continuous Arteriovenous Hemofiltration (CAVH)
Slow continuous ultrafiltration (SCUF) and continuous arteriovenous hemofiltration (CAVH) have been utilized at The Cleveland Clinic Foundation, Department of Hypertension and Nephrology since 1977 in over 150 patients as a clinical therapy for the treatment of acute renal failure.
The purpose of this chapter is to instruct and educate the medical personnel in direct contact with patients who require SCUF and/or CAVH with regard to the practical set-up, monitoring, and management of this continuous renal replacement therapy. This includes the general description and design of the extracorporeal circuit, including suggestions for successful operation and management for the on-going monitoring and regimen involved in this therapy to provide an easy, simple, yet effective outline of practical “how to” description of operation. In order to provide optimal results and benefit to the patient undergoing SCUF or CAVH a technical description and understanding is essential for the success of this modality of treatment.
KeywordsCatheter Filtration Heparin Epinephrine Lidocaine
Unable to display preview. Download preview PDF.
- 3.Amicon Corp., Danvers, MA, 01923. Amicon Models 20 & 30 hemofilters & A-V blood lines.Google Scholar
- 4.Gambro Inc., Barrington, IL, 60010. Ref. for FH-55 hemofilters & A-V blood lines.Google Scholar
- 5.Hospal Med Corp., E. Brunswick, NJ, 08816. Ref for Biospal 1200 S Plate Dialyzer used for SCOF/CAVH & A-V blood tubing sets.Google Scholar
- 6.Castro LA, Banthien F, Gurland HJ: Successful clinical experience in use of small filter sheet dialyzer for CAVH.Google Scholar
- 7.Lifemed Corp., Ref. for A-V blood tubing sets for SCUF/CAVH, Compton CA, 90220.Google Scholar
- 8.International Technidyne Corp., Metuchen, NJ, 08840. Ref. for Hemochron 400 for activated clotting time control.Google Scholar
- 9.Vitalmetrics Inc., San Diego, CA, 92121. Ref for Electronic digital urinary monitoring system.Google Scholar
- 10.Travenol Labs, Deerfield IL, 60015. Ref for CAVH replacement solution kits.Google Scholar
- 12.Shanillin N, Ploth DW: Evaluation of an activated clotting time technique for use in hemodialysis. Dial Transpl 9(10): 955–957, 1980.Google Scholar
- 14.Seldinger SI: Catheter replacement of the needle in percutaneous arteriography. Acta Radiol (Stockh) 20:368–376, 1939.Google Scholar
- 17.Wellington JL: Expanded polytetrafluoroethylene prosthetic grafts for blood access in patients on dialysis. Surgery 21:42–422, 1978.Google Scholar
- 18.Cohen PG: Circulatory access for extracorporeal blood modification. Plasma Therapy 2:235, 1982.Google Scholar
- 20.Grone HJ, Kramer P: Puncture and long term cannulation of the femoral artery and vein in adults in continuous arterio-venous hemofiltration. Vandenhoeck & Ruprecht, 1982.Google Scholar
- 21.Ulbricht C, Schnrek HJ, Tytul S, et al: Efficacy of CAVH in acute renal failure influence of blood pressure, blood flow, vascular access, and filter type, (abstract). Blood Purification 2:57, 1984.Google Scholar
- 22.Lauer A, Saccaggi A, Ronco C, et al: Continuous arteriovenous hemofiltration in the critically ill patient. Ann Intern Med 99:450, 1983.Google Scholar
- 23.Paganini EP: Unpublished data.Google Scholar